山东药玻
(600529)
| 流通市值：189.00亿 | | | 总市值：189.00亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,267,462,044.57 | 4,982,198,167.78 | 3,673,747,350.74 | 2,422,366,308.98 |
| 营业收入 | 1,267,462,044.57 | 4,982,198,167.78 | 3,673,747,350.74 | 2,422,366,308.98 |
| 二、营业总成本 | 1,004,324,485.1 | 4,070,167,292.14 | 2,949,611,615.53 | 1,967,479,550.47 |
| 营业成本 | 879,800,724.18 | 3,585,499,473.26 | 2,637,427,456.74 | 1,770,256,717.68 |
| 税金及附加 | 11,545,327.72 | 46,897,729.69 | 33,704,003.3 | 23,037,156.95 |
| 销售费用 | 28,851,372.97 | 147,502,154.89 | 98,100,823.04 | 60,410,000.44 |
| 管理费用 | 55,382,427.3 | 187,987,428.35 | 115,722,340.11 | 75,446,242.66 |
| 研发费用 | 39,921,990.72 | 137,948,117.32 | 93,377,102.4 | 62,571,323.03 |
| 财务费用 | -11,177,357.79 | -35,667,611.37 | -28,720,110.06 | -24,241,890.29 |
| 其中:利息费用 | 7,728.06 | 226,814.36 | 186,618.53 | 176,820.42 |
| 其中:利息收入 | 5,805,226.07 | 22,722,495.01 | 18,088,885.34 | 12,684,770.35 |
| 加:公允价值变动收益 | 7,633,983.58 | 22,828,648.12 | 16,932,928.19 | 10,162,735.59 |
| 加:投资收益 | 1,952,861.83 | 18,399,071.4 | 15,361,752.61 | 13,279,592.39 |
| 资产处置收益 | 231,940.06 | -5,726,646.98 | -241,687.91 | 270,012.97 |
| 资产减值损失(新) | - | -42,307,905.94 | -11,341,523.46 | -9,047,899.15 |
| 信用减值损失(新) | -5,537,938.1 | -11,388,837.66 | -11,173,781.74 | -9,515,877.03 |
| 其他收益 | 6,757,682.48 | 22,531,664.34 | 8,141,670.27 | 5,558,719.95 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 274,176,089.32 | 916,366,868.92 | 741,815,093.17 | 465,594,043.23 |
| 加:营业外收入 | 780,936.2 | 2,488,840.07 | 2,202,421.71 | 1,331,036.25 |
| 减:营业外支出 | 669,244.49 | 8,031,912.68 | 13,069,915.77 | 6,527,267.82 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 274,287,781.03 | 910,823,796.31 | 730,947,599.11 | 460,397,811.66 |
| 减:所得税费用 | 53,498,382.49 | 135,021,781.69 | 116,713,474.61 | 74,892,931.75 |
| 六、净利润 | 220,789,398.54 | 775,802,014.62 | 614,234,124.5 | 385,504,879.91 |
| 持续经营净利润 | 220,789,398.54 | 775,802,014.62 | 614,234,124.5 | 385,504,879.91 |
| 归属于母公司股东的净利润 | 220,789,398.54 | 775,802,014.62 | 614,234,124.5 | 385,504,879.91 |
| (一)基本每股收益 | 0.33 | 1.17 | 0.93 | 0.58 |
| (二)稀释每股收益 | 0.33 | 1.17 | 0.93 | 0.58 |
| 九、综合收益总额 | 220,789,398.54 | 775,802,014.62 | 614,234,124.5 | 385,504,879.91 |
| 归属于母公司股东的综合收益总额 | 220,789,398.54 | 775,802,014.62 | 614,234,124.5 | 385,504,879.91 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-19 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |